首页> 外文期刊>Journal of thrombosis and thrombolysis >The diagnostic performance of APC-PCI complex determination compared to D-dimer in the diagnosis of deep vein thrombosis.
【24h】

The diagnostic performance of APC-PCI complex determination compared to D-dimer in the diagnosis of deep vein thrombosis.

机译:与D-二聚体相比,APC-PCI复合物测定在诊断深静脉血栓形成中的诊断性能。

获取原文
获取原文并翻译 | 示例
           

摘要

D-dimer testing is widely used as part of the diagnostic algorithm for the exclusion of deep vein thrombosis (DVT) but is considered of limited in value for ruling DVT in. Since D-dimers are poorly defined, there is no standardization of the assays and this makes reliable comparisons between clinical studies difficult. We report on a performance evaluation of a new marker of activated coagulation (Activated Protein-C in complex with Protein-C inhibitor, APC-PCI complex) compared to two quantitative D-dimer assays (Vidas D-dimer Exclusion and Autodimer). The post-hoc comparison was made on 350 frozen plasma samples from consecutive outpatients suspected of DVT in a multicenter management study including clinical probability score, D-dimer testing, venous ultrasound and contrast venography as part of the diagnostic algorithm. RESULTS: The APC-PCI complex performed inferior to the D-dimer assays in terms of sensitivity: 74 vs. >93%, negative predictive value: 91 vs. >96% and area under the curve: 0.82 vs. 0.9, but showed a significantly higher specificity: 80 vs. 40-60%. Specificity for the APC-PCI complex did not decrease with higher clinical probability score and the positive predictive value was significantly higher than that of the D-dimer assays in the intermediate/high probability cohort (66 vs. <52%). In this probability cohort, high levels of the APC-PCI complex and to a lesser extent, D-dimers, can give positive predictive values of >90% in up to 20% of the patients which indicates important clinical implications. However, for the exclusion of DVT at the pre-specified cut-off level, the APC-PCI complex perform inferior to the D-dimer assays in this study.
机译:D-二聚体测试被广泛用作排除深静脉血栓形成(DVT)的诊断算法的一部分,但被认为对DVT的诊断价值有限。由于D-二聚体定义不明确,因此没有标准化的测定方法因此很难进行临床研究之间的可靠比较。我们报告了与两个定量D-二聚体测定法(维达斯D-二聚体排除法和自体二聚体)相比,活性凝结的新标记(与Protein-C抑制剂复合的A蛋白-PCI复合物中的活化Protein-C)的性能评估。在多中心管理研究中,对来自连续疑似DVT的连续门诊患者的350份冷冻血浆样本进行事后比较,包括临床概率评分,D-二聚体测试,静脉超声和造影剂静脉造影,作为诊断算法的一部分。结果:APC-PCI复合物在灵敏度方面低于D-二聚体测定:74比> 93%,阴性预测值:91比> 96%,曲线下面积:0.82比0.9,但显示更高的特异性:80比40-60%。在较高的临床概率评分中,APC-PCI复合物的特异性并未降低,在中/高概率队列中,阳性预测值显着高于D-二聚体测定法(66 vs. <52%)。在这种可能性队列中,高水平的APC-PCI复合物和较小程度的D-二聚体可在多达20%的患者中给出大于90%的阳性预测值,这表明具有重要的临床意义。但是,在预定的临界水平上排除DVT时,本研究中APC-PCI复合物的性能不如D-二聚体测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号